Last updated on: 6/1/2009 | Author:

Joep Killestein, MD, PhD Biography

Multiple Sclerosis Researcher in the Department of Neurology at the MS Centre at VU Medical Centre in Amsterdam
Not Clearly Pro or Con to the question "Should Marijuana Be a Medical Option?"

“The authors conducted a randomized, double-blind, placebo-controlled, twofold crossover study in 16 patients with MS who presented with severe spasticity to investigate safety, tolerability, and efficacy of oral Delta(9)-Tetrahydrocannabinol (THC) and Cannabis sativa plant extract. Both drugs were safe, but adverse events were more common with plant-extract treatment. Compared with placebo, neither THC nor plant-extract treatment reduced spasticity. Both THC and plant-extract treatment worsened the participant’s global impression.”

“Safety, Tolerability, and Efficacy of Orally Administered Cannabinoids in MS,” Neurology , May 2

Involvement and Affiliations:
  • Multiple Sclerosis (MS) Researcher, Department of Neurology, MS Centre, VU Medical Centre, Amsterdam, The Netherlands
  • MD, School unknown
  • PhD, School unknown
  • None found